First Time Loading...
R

Redx Pharma PLC
LSE:REDX

Watchlist Manager
Redx Pharma PLC
LSE:REDX
Watchlist
Price: 15 GBX 31.58% Market Closed
Updated: May 7, 2024

Redx Pharma PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redx Pharma PLC
Revenue Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
R
Redx Pharma PLC
LSE:REDX
Revenue
£4.2m
CAGR 3-Years
-10%
CAGR 5-Years
101%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Revenue
£30.7B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Revenue
$47.6B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Revenue
$1.1B
CAGR 3-Years
19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Revenue
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
8%
Dechra Pharmaceuticals PLC
LSE:DPH
Revenue
£761.5m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Redx Pharma PLC's Revenue?
Revenue
4.2m GBP

Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Revenue amounts to 4.2m GBP.

What is Redx Pharma PLC's Revenue growth rate?
Revenue CAGR 5Y
101%

Over the last year, the Revenue growth was -78%. The average annual Revenue growth rates for Redx Pharma PLC have been -10% over the past three years , 101% over the past five years .